Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14941
The Transport Behavior of a Biflagellated Microswimmer before and after Cargo Loading
Published 2021“…In this work, we show the change in swimming behavior of biflagellated microalgae Chlamydomonas reinhardtii picking up a 4.5 μm polystyrene microbead upon collision. …”
-
14942
The Transport Behavior of a Biflagellated Microswimmer before and after Cargo Loading
Published 2021“…In this work, we show the change in swimming behavior of biflagellated microalgae Chlamydomonas reinhardtii picking up a 4.5 μm polystyrene microbead upon collision. …”
-
14943
-
14944
Activity coupling between V2 and the CPu.
Published 2018“…(F) Comparison of the maximal coherence values between 40–55 Hz and 5–50 ms (marked by a dashed white box on (D)). …”
-
14945
Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA.
Published 2009“…(<b>B</b>) ChIP analysis of <i>PC3</i> binding to the <i>Id3</i> promoter in PC12 cells, treated as shown in (<b>A</b>). A scheme above the graph describes the <i>Id3</i> gene and the promoter region analyzed, 700 nt 5′ to the transcription start. …”
-
14946
Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial
Published 2017“…Dietary AGE restriction resulted in a significant decrease in serum N<sup><i>ε</i></sup>-(carboxymethyl) lysine (CML) and methylglyoxal-derivatives (MG). …”
-
14947
-
14948
-
14949
Decreased proliferation in <i>Csf1r<sup>−/−</sup></i> and <i>Csf1<sup>op/op</sup></i> mouse colonic epithelium.
Published 2013“…Bar = 50 µm. Means are depicted by horizontal bars, n = 3 per group, *<b>*</b>P<0.01, *P<0.05, using unpaired two-tailed t-test. …”
-
14950
Data_Sheet_1_Intracellular Staphylococcus aureus Infection Decreases Milk Protein Synthesis by Preventing Amino Acid Uptake in Bovine Mammary Epithelial Cells.pdf
Published 2021“…Thus mTORC1 regulates the expression of SLC1A3 and SLC7A5 through NF-κB and STAT5. These findings constitute a model by which S. aureus infection suppresses milk protein synthesis by decreasing amino acids uptake in BMECs.…”
-
14951
-
14952
-
14953
-
14954
-
14955
-
14956
Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice - Fig 3
Published 2018“…In WT mice a decreasing effect on plasma VEGF-A was seen (a). …”
-
14957
Table_5_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx
Published 2022“…AZA, MMF, OC and RTX showed a trend to decrease ARR, but those results did not reach significant differences. …”
-
14958
PCAIs inhibit NCI-H23 cell line viability.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
14959
PCAIs disrupt actin filaments in NCI-H23 cells.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
14960
PCAIs suppress 3D NCI-H23 cell invasion.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”